Nipah monoclonal antibody to undergo human trials in India, Bangladesh in 2025
New Delhi: A novel monoclonal antibody against the Nipah virus is set to undergo human clinical trials in India, and Bangladesh — two countries that suffer Nipah outbreaks almost every year — in 2025, according to a report on Thursday. Nipah virus, a zoonotic disease of the Paramyxovirus family, kills up to 75 per cent